Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
$49.46
pos +0.35
+0.71%
Today's Range: 48.95 - 49.68 | BMY Avg Daily Volume: 9,364,900
Last Update: 04/17/14 - 4:01 PM EDT
Volume: 6,670,783
YTD Performance: -6.94%
Open: $49.04
Previous Close: $49.11
52 Week Range: $39.18 - $57.49
Oustanding Shares: 1,650,232,566
Market Cap: 81,373,919,131
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 1 1 1 1
Hold 4 4 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 1 1
Mean Rec. 2.03 2.03 1.97 1.97
Latest Dividend: 0.36
Latest Dividend Yield: 2.63%
Dividend Ex-Date: 04/02/14
Price Earnings Ratio: 35.54
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
35.54 31.80 29.01
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.01% 21.20% 77.40%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.90 -0.13 -0.05
Earnings for BMY:
EBITDA 3.86B
Revenue 16.39B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.44 $0.44 $1.76 $1.71
Number of Analysts 10 8 13 11
High Estimate $0.48 $0.49 $1.82 $2.01
Low Estimate $0.40 $0.41 $1.68 $1.37
Prior Year $0.41 $0.44 $1.82 $1.76
Growth Rate (Year over Year) 7.07% 0.28% -3.42% -2.51%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Mar 29, 2014 | 8:00 AM EDT

TheStreet's Jim Cramer says newer pharmaceutical companies, like Celgene (CELG), Isis Pharmaceuticals (ISIS) and Seattle Genetics (SGEN), should be bought on any weakness because they have the potential to perform extremely well and may be better buys than Pfizer, Merck, Bristol-Myers and Eli Lilly.

By

Jim Cramer

 | Mar 24, 2014 | 2:16 PM EDT

If they're renters, they can hurt you, and if they're owners, they can help.

By

Jim Cramer

 | Mar 14, 2014 | 6:46 AM EDT

There are stocks that benefit from whatever's causing the decline.

By

Jim Cramer

 | Mar 5, 2014 | 4:36 PM EST

Even the bulls are keeping one foot out the door.

By

Jim Cramer

 | Mar 5, 2014 | 8:03 AM EST

These sectors almost never see the kind of rallies they just had.

updateCredit Suisse Healthcare Conf.

Mar 4, 2014 | 7:13 AM EST

Credit Suisse Healthcare Conference - 03/04/14 - 03/05/14 

By

Jim Cramer

 | Mar 2, 2014 | 10:00 PM EST

A 5-day look at how situations like Ukraine have played out.

By

Jim Cramer

 | Feb 11, 2014 | 6:56 AM EST

Monday's session was one any bull has to fear.

bullishBristol-Myers upgraded at BMO

Feb 10, 2014 | 7:59 AM EST

BMY was upgraded from Market Perform to Outperform, BMO Capital said. $60 price target. Immuno-oncology pipeline should drive growth in the coming quarters. 

By

Paul Price

 | Feb 4, 2014 | 9:30 AM EST

Management expects another record EPS year in 2014.

There were nice reversal-type candles on the weekly charts of the major indices. The DOW a...
A number of stocks on my watch lists are attempting to form positive candles a key suppor...
While last week was a day to pull the plug and contemplate where the market was headed, I ...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: t...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.